A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer (vol 24, 876, 2024)
Por:
Leary, A, Estévez-García, P, Sabatier, R, Ray-Coquard, I, Romeo, M, Barretina-Ginesta, P, Gil-Martin, M, Garralda, E, Bosch-Barrera, J, Morán, T, Martin-Martorell, P, Nadal, E, Gascón, P, Rodon, J, Lizcano, JM, Muñoz-Guardiola, P, Fierro-Durán, G, Pedrós-Gámez, O, Pérez-Montoyo, H, Yeste-Velasco, M, Cortal, M, Pérez-Campos, A, Alfon, J, Domenech, C, Pérez-Fidalgo, A and Oaknin, A
Publicada:
29 jul 2024
Resumen:
Filiaciones:
Leary, A:
Inst Gustave Roussy, Med Oncol, Villejuif, France
Estévez-García, P:
Hosp Univ Virgen Rocio, Med Oncol, Seville, Spain
Sabatier, R:
Aix Marseille Univ, Inst Paoli Calmettes, Dept Med Oncol, Inserm,CNRS, 232 Blvd Sainte Marguer, Marseille, France
Ray-Coquard, I:
Ctr Leon Berard, Med Oncol, Lyon, France
:
Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Germans Trias & Pujol Inst, Badalona Appl Res Grp Oncol,Dept Med Oncol,Dept Me, Badalona, Spain
Barretina-Ginesta, P:
Univ Girona UdG, Girona Biomed Res Inst IDIBGI, Med Sch, Precis Oncol Grp OncoGIR Pro,Med Oncol Dept, Girona, Spain
Univ Girona UdG, Inst Catala Oncol ICO, Med Sch, Dept Med Sci, Girona, Spain
Gil-Martin, M:
Catalan Inst Oncol, Med Oncol, Barcelona, Spain
IDIBELL, Barcelona, Spain
Garralda, E:
Vall dHebron Inst Oncol VHIO, Med Oncol Serv, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
Bosch-Barrera, J:
Univ Girona UdG, Girona Biomed Res Inst IDIBGI, Med Sch, Precis Oncol Grp OncoGIR Pro,Med Oncol Dept, Girona, Spain
Univ Girona UdG, Inst Catala Oncol ICO, Med Sch, Dept Med Sci, Girona, Spain
Morán, T:
Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Germans Trias & Pujol Inst, Badalona Appl Res Grp Oncol,Dept Med Oncol,Dept Me, Badalona, Spain
Martin-Martorell, P:
Hosp Clin Univ, Med Oncol, INCLIVA, Valencia, Spain
Nadal, E:
Catalan Inst Oncol, Med Oncol, Barcelona, Spain
IDIBELL, Barcelona, Spain
Gascón, P:
Univ Barcelona, Hosp Clin, Med Oncol Serv, Barcelona, Spain
Rodon, J:
Univ Texas MD Anderson Canc Ctr, Early Drug Dev, Houston, TX USA
Lizcano, JM:
Univ Autonoma Barcelona, Inst Neurociencias, Dept Biochem & Mol Biol, Barcelona, Spain
Vall Hebron Inst Recerca VHIR, Prot Kinases Canc Res, Barcelona, Spain
Muñoz-Guardiola, P:
Univ Autonoma Barcelona, Inst Neurociencias, Dept Biochem & Mol Biol, Barcelona, Spain
Abil Pharmaceut, Res & Dev, Barcelona, Spain
Fierro-Durán, G:
Abil Pharmaceut, Res & Dev, Barcelona, Spain
Pedrós-Gámez, O:
Abil Pharmaceut, Res & Dev, Barcelona, Spain
Pérez-Montoyo, H:
Abil Pharmaceut, Res & Dev, Barcelona, Spain
Yeste-Velasco, M:
Abil Pharmaceut, Res & Dev, Barcelona, Spain
Cortal, M:
Abil Pharmaceut, Res & Dev, Barcelona, Spain
Pérez-Campos, A:
Abil Pharmaceut, Res & Dev, Barcelona, Spain
Alfon, J:
Abil Pharmaceut, Res & Dev, Barcelona, Spain
Domenech, C:
Abil Pharmaceut, Res & Dev, Barcelona, Spain
Pérez-Fidalgo, A:
Hosp Clin Univ, Med Oncol, INCLIVA, Valencia, Spain
Oaknin, A:
Vall dHebron Inst Oncol VHIO, Med Oncol Serv, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
Green Submitted, gold
|